Notice ID: 773e6eeff05a4dbb91f7bc8da6d99552Special Notice
6515--Orthopedic and Podiatry clinics; Ossatron Treatments
Archived on September 3, 2021. Full description on SAM.gov.
Overview
- Posted
- August 4, 2021
- Notice type
- Special Notice
Notice details
- Office
- 247-NETWORK CONTRACT OFFICE 7 (36C247)
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C24721Q1122
- Notice ID
- 773e6eeff05a4dbb91f7bc8da6d99552
Description
Intent to Sole Source 36C24721Q1122. This is an Intent to Sole Source, this is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to provide information based on this requirement. The Department of Veterans Affairs, NCO 7 Regional Procurement Office - East on behalf of the VA Augusta, GA intends to award a Firm-Fixed-Price sole source award to Premier Shockwave, Inc. for the to provide an OssaTron medical device, consumables, and technician for Plantar Fasciitis, Achilles Tendonitis, Lateral Epicondylitis, Patellar Tendonitis, Tricep Tendonitis, Metatarsalgia and other indicated procedures. The Orthopedic and Podiatry clinics treat patients suffering chronic pain from various tendinopathy conditions that are currently being managed by pain medications. One of the doctors has experience with the use of high- energy electro-hydraulic extracorporeal shockwave device (OssaTron) and found it to be effective in treating these conditions. This sole source award to Premier Shockwave, Inc. is in accordance with 41 U.S.C. 3304 as implemented by way of the procedures outline in the Federal Acquisition Regulation (FAR) subpart 6.302-1 Only one responsible source and no other supplies or services will satisfy agency requirements. This is not a request for competitive offers, quotes, or capability statements. No solicitation will be posted as a result of this notice. This Special Notice is being issued for information purpose only. NAICS:334510 , SBA Size Standard: 1250 Employees, PSC: 6515. END OF INTENT TO SOLE SOURCE. All sources eligible to meet this requirement must respond in writing and challenges to this Intent to Sole Source shall be sent to Darlene.Chase@va.gov no later than 11:00AM EST on August 11, 2021, if no responses are received by 11:00AM EST on August 11, 2021 to demonstrate comparable capability, then a sole source acquisition award will be made. DEPARTMENT OF VETERANS AFFAIRS Justification and Approval (J&A) For Other Than Full and Open Competition (>SAT) Acquisition Plan Action ID: Contracting Activity: Department of Veterans Affairs, VISN 7, Charlie Norwood VA Medical Center, Augusta GA, 30904. Nature and/or Description of the Action Being Processed: This is a new firm-fixed price contract to obtain the use of high-energy electro-hydraulic extracorporeal shockwave device that is FDA Approved to treat multiple tendinopathies: Plantar Fasciitis, Achilles Tendonitis, Lateral Epicondylitis, Patellar Tendonitis, Tricep Tendonitis, and Metatarsalgia. Description of Supplies/Services Required to Meet the Agency s Needs: The vendor will provide an OssaTron machine and all consumables required to perform tendinopathy procedures to treat Veteran s suffering chronic pain from Plantar Fasciitis, Achilles Tendonitis, Lateral Epicondylitis, Patellar Tendonitis, Tricep Tendonitis, and Metatarsalgia. The OssaTron device is the only high- energy electro-hydraulic extracorporeal shockwave device that is FDA Approved to treat chronic plantar fasciitis & chronic lateral epicondylitis. This is the only device that can be used by Orthopedists & Podiatrists to perform these procedures. There are two types of tendinopathy procedures that will be performed Bilateral and Unilateral. The hospital estimates it will need to perform 94 Bilateral procedures and 98 Unilateral procedures a piece for an estimated contract cost of per year. The procedures will be performed over a 12-month period from the award date of this contract and include 4 option years over 5 years. Statutory Authority Permitting Other than Full and Open Competition: (X) (1) Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 USC §3304(a)(1) as implemented by FAR 6.302-1; ( ) (2) Unusual and Compelling Urgency per 41 USC §3304(a)(2) as implemented by FAR 6.302-2; ( ) (3) Industrial Mobilization, Engineering, Developmental or Research Capability or Expert Services per 41 USC §3304(a)(3) as implemented by FAR 6.302-3; ( ) (4) International Agreement per 41 USC §3304(a)(4) as implemented by FAR 6.302-4 ( ) (5) Authorized or Required by Statute per 41 USC §3304(a)(5) as implemented by FAR 6.302-5; ( ) (6) National Security per 41 USC §3304(a)(6) as implemented by FAR 6.302-6; ( ) (7) Public Interest per 41 USC §3304(a)(7) as implemented by FAR 6.302-7; FAR13.5 Simplified Procedures for Certain Commercial Items: N/A Demonstration that the Contractor s Unique Qualifications or Nature of the Acquisition Requires the Use of the Authority Cited Above (applicability of authority): Premier Shockwave Inc., is the only source that provides mobile OssaTron devices to hospital and doctor offices nationwide. Through a series of transactions, Premier Shockwave has purchased 70 of the 72 OssaTrons that OFOC SOP Revision 09 Original Date: 03/22/11 Revision 09 Date: 04/17/2020 Page 1 of 4 were brought legally into the United States. The company that produced the devices went bankrupt in 2005 and no longer produces the devices. There is not a substitute product capable of providing the treatments the OssaTron devices provide and there is no manufacture producing this machine or any comparable product. Premier Shockwave must sole source all replacement and consumable parts to keep their devices working at OEM specifications. The use of the OssaTron device is the most effective treatment found to treat plantar fasciitis, tennis elbow, patellar/achilleas tendonitis and is essential to provide treatment and relief to the veterans suffering from these conditions. Accordingly, Premier Shockwave Inc. is the only firm capable of providing the supplies and services described in Section III above without the Veteran s Health Administration experiencing substantial duplication of cost that could not be expected to be recovered through competition Description of Efforts Made to ensure that offers are solicited from as many potential sources as deemed practicable: Determination by the CO that the Anticipated Cost to the Government will be Fair and Reasonable: Premier Shockwave Inc. is the only provider of this service and has not raised their prices for services since 2008 thus the price being offered is considered fair and reasonable Description of the Market Research Conducted and the Results, or a Statement of the Reasons Market Research Was Not Conducted: Based on past knowledge of performing these procedures and recent web searches for additional sources has determined there is only one commercially available source for portable OssaTron Treatments. Premier Shockwave Inc. is the only known vendor in the United States that has high-energy electro-hydraulic extracorporeal shockwave devices capable of meeting the government s needs. They have an active registration with System for Award Management as a small business with no other socio-economic status listed. Any Other Facts Supporting the Use of Other than Full and Open Competition: Premier Shockwave Inc., is the only source that provides mobile OssaTron, there is no other vendor capable of meeting the government s needs. Listing of Sources that Expressed, in Writing, an Interest in the Acquisition: Premier Shockwave Inc. 3360 Martin Farm Road, Suite 100B Suwanee, GA 30024, A Statement of the Actions, if any, the Agency May Take to Remove or Overcome any Barriers to Competition before Making subsequent acquisitions for the supplies or services required: Until a manufacture begins producing additional OssaTron devices or an acceptable replacement capable of providing Bilateral and Unilateral Tenopathy procedures there is not a way to overcome this competition barrier. Since no other sources are available to provide this treatment, we are requesting option years be provided for this contract. Requirements Certification: I certify that the requirement outlined in this justification is a Bona Fide Need of the Department of Veterans Affairs and that the supporting data under my cognizance, which are included in the justification, are accurate and complete to the best of my knowledge and belief. OFOC SOP Revision 09 Original Date: 03/22/11 Revision 09 Date: 04/17/2020 Page 2 of 4 I - - I - - - d. - - -- OFOC SOP Revision 09 Original Date: 03/22/11 Revision 09 Date: 04/17/2020 Page 4 of 4
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24721Q1122- Special NoticeCurrentAug 4, 2021
6515--Orthopedic and Podiatry clinics; Ossatron Treatments
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Seeking Service-Disabled Veteran-Owned Small Business (SDVOSB) and Veteran-Owned Small Business (VOSB) sources capable of providing the audiology equipment and services listed in the attached document. | 78% | Market Research | 10/08/2026 |
Seeking Service-Disabled Veteran-Owned Small Business (SDVOSB) and Veteran-Owned Small Business (VOSB) sources capable of providing the audiology equipment and services listed in the attached document. | 78% | Market Research | 10/08/2026 |
Seeking Service-Disabled Veteran-Owned Small Business (SDVOSB) and Veteran-Owned Small Business (VOSB) sources capable of providing the audiology equipment and services listed in the attached document. | 78% | Market Research | 10/08/2026 |
The purpose of this amendment is to: Update the SLA Rate Fee. The SLA Rate Fee for all NX contracts has decreased from 3.0% to 0.5%. Because of this change, pricing and Clause SAC 18-01, "SAC/EPO SLA Fee and Submission of Quarterly Sales Reports," must be updated on existing NX contracts through a unilateral modification. Effective immediately, solicitations must list the 0.5% SLA Rate Fee in the clause referenced above and embed it in Attachment A, the Price/Cost Schedule. Update the Contracting Office Address (office name) from Enterprise Procurement Contracting to Enterprise Procurement Office (EPO). Update the Government Point of Contact s phone number from 770-468-3143 to 678-428-5319. Clause C.2 (EPO 18-01) of the solicitation has been revised as shown below, and a revised Attachment A, Price/Cost Schedule for the NX EQ Ultrasonic Aspirator System Tissue Ablation (dated 11/18/2026), is attached. C.2 EPO 18-01 EPO SERVICE LEVEL AGREEMENT FEE AND SUBMISSION OF QUARTERLY SALES REPORTS: OPEN MARKET (JAN 2016) a. Service Level Agreement Fee. The Service Level Agreement (SLA) fee is established by the Supply Fund Board and is provided as a means of reimbursement for customary acquisition-related services necessary to obtain contractor services and/or supplies as required. The SLA is reimbursed to the EPO based on rates established by the supply fund board and are recouped based on a percentage of total quarterly sales. The Supply Fund Board may change the percentage at any time, but typically not more than once per year. Upon a change in the SLA, the Contracting Officer (CO) shall issue a unilateral modification to apply the change to CLIN prices based upon the SLA rate change. The EPO will provide reasonable notice prior to the effective date of the change. In order to facilitate SLA reimbursement, offerors must include (imbed) the SLA fee into their prices; therefore, the fee will be reflected in the total amount charged and transparent to ordering activities. The current SLA which applies to this contract action is 0.5%. This SLA Fee shall be imbedded in the awarded contract/agreement price(s) and offers submitted in response to this solicitation shall include this SLA Fee in the price of every line item offered. b. Quarterly Sales Reports. The Contractor must report all contract sales under this contract and submit collected SLAs as follows: (1) The Contractor must accurately report the dollar value, in U.S. dollars and rounded to the nearest whole dollar, of all sales made under this contract by calendar quarter (January 1 March 31, April 1 June 30, July 1 September 30, and October 1 December 31). Reported sales must include all sales made to all authorized contract or agreement users, whether shipped directly to the users or through Prime Vendor contractors. The report must reflect sales by contract line item and segment sales by the Department of Veterans Affairs (VA) and Other Government Agencies (OGA). The reported contract sales must include the SLA Fee and each quarterly report must show the total SLA Fee amount collected on the reported sales. The Contractor must maintain a consistent accounting method of sales reporting, based on the Contractor s established commercial accounting practice. The Contractor must consistently use only one of the following acceptable points at which sales may be reported- i. Receipt of order; ii. Shipment or delivery, as applicable; iii. Issuance of an invoice; or iv. Payment. (2) Sales under this contract/agreement shall be reported to the EPO within 60 calendar days following the completion of each reporting quarter. The Contractor must continue to furnish quarterly reports, including zero sales, through physical completion of the last outstanding order of the contract/agreement. (3) The sales report signed by an authorized representative of the contractor shall be emailed to the appropriate individual(s) listed in the terms and conditions of the contract or agreement. c. SLA Remittance The Contractor must remit the SLA fee to the EPO in U.S. dollars within 60 calendar days after the end of the reporting quarter and final payment shall be remitted within 60 days after physical completion of the last outstanding task order or delivery order of the contract. The SLA Fee amount collected and due shall be paid electronically. To ensure that the payment is credited properly, the Contractor must electronically transmit the SLA fee along with the coinciding quarterly sales report at www.pay.gov (VA Enterprise Procurement Office (EPO)); specific instructions must be provided when the contract action resulting from this solicitation is awarded (i.e. post-award/BPA issuance conference and/or post-award letter when used in lieu of a conference). The Government reserves the right to inspect, without further notice, such records of the Contractor as pertinent to sales under any contract or agreements resulting from this solicitation. Failure to remit the full amount of the SLA within 60 calendar days after the end of the applicable reporting period constitutes a contract debt to the United States Government under the terms of Revolutionary Federal Acquisition Regulation (FAR) Overhaul (RFO) Subpart 32.6. The Government may exercise all rights under the Debt Collection Improvement Act of 1996, including withholding or setting off payments and interest on the debt (see RFO clause 52.232-17, Interest). Should the Contractor fail to submit the required sales reports, falsify them, or fail to timely pay the SLA, the Government shall have, in addition to the rights and remedies described in this clause, all other rights and remedies permitted by Federal law and statutes. (End of Clause) | 68% | Combined Synopsis | 12/01/2026 |
Combine Synopsis Please refer to attached Solicitation and Cover Letter. | 68% | Combined Synopsis | 11/23/2026 |
Additional Details
Solicitation Number
36C24721Q1122
Archive Date
Sep 3, 2021
Office Address
AUGUSTA, GA, 30904